Literature DB >> 2903229

Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers.

J J LiPuma1, J E Mortensen, S E Dasen, T D Edlind, D V Schidlow, J L Burns, T L Stull.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2903229     DOI： 10.1016/s0022-3476(88)80018-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  33 in total

1.  Molecular epidemiological investigation using a randomly amplified polymorphic DNA assay of Burkholderia cepacia isolates from nosocomial outbreaks.

Authors:  M Okazaki; T Watanabe; K Morita; Y Higurashi; K Araki; N Shukuya; S Baba; N Watanabe; T Egami; N Furuya; M Kanamori; S Shimazaki; H Uchimura
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex.

Authors:  E Mahenthiralingam; T Coenye; J W Chung; D P Speert; J R Govan; P Taylor; P Vandamme
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Intercontinental spread of a highly transmissible clone of Pseudomonas cepacia proved by multilocus enzyme electrophoresis and ribotyping.

Authors:  W M Johnson
Journal:  Can J Infect Dis       Date:  1994-03

4.  DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak.

Authors:  D J Anderson; J S Kuhns; M L Vasil; D N Gerding; E N Janoff
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

5.  Molecular genetic basis of ribotyping.

Authors:  Valérie Bouchet; Heather Huot; Richard Goldstein
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

6.  Pseudomonas cepacia in cystic fibrosis.

Authors:  D E Stableforth; D L Smith
Journal:  Thorax       Date:  1994-07       Impact factor: 9.139

7.  Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center.

Authors:  H Vu-Thien; D Moissenet; M Valcin; C Dulot; G Tournier; A Garbarg-Chenon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-11       Impact factor: 3.267

8.  Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis.

Authors:  E Mahenthiralingam; D A Simpson; D P Speert
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

9.  Regulator LdhR and d-Lactate Dehydrogenase LdhA of Burkholderia multivorans Play Roles in Carbon Overflow and in Planktonic Cellular Aggregate Formation.

Authors:  Inês N Silva; Marcelo J Ramires; Lisa A Azevedo; Ana R Guerreiro; Andreia C Tavares; Jörg D Becker; Leonilde M Moreira
Journal:  Appl Environ Microbiol       Date:  2017-09-15       Impact factor: 4.792

10.  Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis.

Authors:  G Y Larsen; T L Stull; J L Burns
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.